A major Murdoch University review has found that for many people with multiple sclerosis (MS), walking is hindered not only by physical symptoms but also by external emotional and societal challenges.

Telerehabilitation improved walking in MS but was not more effective than clinic-based rehabilitation in a large U.S. study.

Fampridine, the first medicine designed to improve walking in adults with multiple sclerosis (MS), will now be routinely available on the NHS in England, NHS England has announced. The twice-daily ...

ORLANDO — An extended-release (ER) formulation of amantadine hydrochloride known as ADS-5102 (Adamas Pharmaceuticals) may be safe and effective for patients with walking impairment from multiple ...

Daily step patterns were associated with MS disability, suggesting they may complement clinic-based assessments, per a study.

On Saturday morning, hundreds of locals will be walking to raise money and support for people with multiple sclerosis. According to the National Multiple Sclerosis Society, 1 in 300 people in Idaho ...